These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18803170)

  • 21. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.
    Piccinni A; Del Debbio A; Medda P; Bianchi C; Roncaglia I; Veltri A; Zanello S; Massimetti E; Origlia N; Domenici L; Marazziti D; Dell'Osso L
    Eur Neuropsychopharmacol; 2009 May; 19(5):349-55. PubMed ID: 19223156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term sertraline treatment and peripheral biochemical markers in female depressed patients.
    Pivac N; Mück-Seler D; Sagud M; Jakovljević M; Mustapić M; Mihaljević-Peles A
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):759-65. PubMed ID: 12921906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute risperidone treatment did not increase daily cigarette consumption or plasma levels of cotinine and caffeine: a pilot study.
    Yoshimura R; Kakihara S; Umene-Nakano W; Sugita A; Hori H; Ueda N; Nakamura J
    Hum Psychopharmacol; 2008 Jun; 23(4):327-32. PubMed ID: 18273830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder.
    Aydemir O; Deveci A; Taskin OE; Taneli F; Esen-Danaci A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1023-6. PubMed ID: 17433517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients.
    Yoshimura R; Shinkai K; Ueda N; Nakamura J
    Pharmacopsychiatry; 2007 Jan; 40(1):9-13. PubMed ID: 17327954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.
    Rothbaum BO; Killeen TK; Davidson JR; Brady KT; Connor KM; Heekin MH
    J Clin Psychiatry; 2008 Apr; 69(4):520-5. PubMed ID: 18278987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder.
    Sato Y; Yasui-Furukori N; Nakagami T; Saito M; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):416-8. PubMed ID: 19166896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A possible tetracycline-risperidone-sertraline interaction in an adolescent.
    Steele M; Couturier J
    Can J Clin Pharmacol; 1999; 6(1):15-7. PubMed ID: 10465861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
    Amsterdam JD; Williams D; Michelson D; Adler LA; Dunner DL; Nierenberg AA; Reimherr FW; Schatzberg AF
    Neuropsychobiology; 2009; 59(4):227-33. PubMed ID: 19571597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in CREB phosphorylation and BDNF plasma levels during psychotherapy of depression.
    Koch JM; Hinze-Selch D; Stingele K; Huchzermeier C; Goder R; Seeck-Hirschner M; Aldenhoff JB
    Psychother Psychosom; 2009; 78(3):187-92. PubMed ID: 19321972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial.
    Brunoni AR; Machado-Vieira R; Zarate CA; Vieira EL; Vanderhasselt MA; Nitsche MA; Valiengo L; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
    Eur Neuropsychopharmacol; 2014 Jul; 24(7):1144-51. PubMed ID: 24702987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of sertraline on blood clozapine].
    Darchy A; Fdhil H; Canceil O
    Encephale; 1998; 24(2):156-7. PubMed ID: 9622795
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls.
    Yoshimura R; Umene-Nakano W; Hoshuyama T; Ikenouchi-Sugita A; Hori H; Katsuki A; Hayashi K; Atake K; Nakamura J
    Hum Psychopharmacol; 2010 Nov; 25(7-8):566-9. PubMed ID: 21312291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder.
    Gustafsson G; Lira CM; Johansson J; Wisén A; Wohlfart B; Ekman R; Westrin A
    Psychiatry Res; 2009 Oct; 169(3):244-8. PubMed ID: 19729204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.
    Bocchio-Chiavetto L; Zanardini R; Bortolomasi M; Abate M; Segala M; Giacopuzzi M; Riva MA; Marchina E; Pasqualetti P; Perez J; Gennarelli M
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):620-4. PubMed ID: 16757154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients.
    Malempati RN; Bond DJ; Yatham LN
    Int Clin Psychopharmacol; 2008 Mar; 23(2):88-94. PubMed ID: 18301123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury.
    Ashman TA; Cantor JB; Gordon WA; Spielman L; Flanagan S; Ginsberg A; Engmann C; Egan M; Ambrose F; Greenwald B
    Arch Phys Med Rehabil; 2009 May; 90(5):733-40. PubMed ID: 19406291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients.
    Schüle C; Baghai TC; Alajbegovic L; Schwarz M; Zwanzger P; Eser D; Schaaf L; Möller HJ; Rupprecht R
    Eur Arch Psychiatry Clin Neurosci; 2005 Oct; 255(5):334-40. PubMed ID: 15747035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin release in children treated with risperidone: impact and role of CYP2D6 metabolism.
    Troost PW; Lahuis BE; Hermans MH; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ
    J Clin Psychopharmacol; 2007 Feb; 27(1):52-7. PubMed ID: 17224713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.